Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03235414
Other study ID # CIN001-Liver stiffness
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 19, 2018
Est. completion date July 24, 2020

Study information

Verified date July 2020
Source Children's Hospital Medical Center, Cincinnati
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Healthy children will be recruited to under Magnetic Resonance Imaging (MRI)along with MR elastography to determine normal liver stiffness values.


Description:

MR elastography (MRE) is playing a growing role in the non-invasive diagnosis and monitoring of liver disease in the pediatric population. There is, however, little data specific to the use of this technique in children with existing data and techniques largely extrapolated from adult studies. Existing studies suggest that liver stiffness values may be different between children and adults [Etchell, Xanthakos]. As such there is an unmet need for uniquely pediatric data in both healthy and diseased cohorts. To address the need for such data, the investigators plan a multi-site, prospective study of healthy pediatric (<18 years of age) volunteers to determine normal liver stiffness measured by MR elastography across the range of MRI equipment.


Recruitment information / eligibility

Status Completed
Enrollment 101
Est. completion date July 24, 2020
Est. primary completion date June 25, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 7 Years to 17 Years
Eligibility Inclusion Criteria:

- Age 7-17 years

- No documented history of liver diseases

- English speaking

Exclusion Criteria:

- NPO less than 4 hours

- Body mass index <10th or > 85th percentile for age

- Documented history of liver disease

- Pregnancy

- Inability to lie still for duration of the MRI

- Inability to breath hold for the duration of the 15-20 second MR elastography sequence

- Standard contraindication to MRI (implanted hardware, etc.)

- Requirement of sedation or general anesthesia for MRI

- Abnormality of any measured liver function test

- Liver fat fraction >5% by MRI PDFF

Study Design


Related Conditions & MeSH terms


Intervention

Device:
MRI
Will receive a one time research MRI (MR elastography)
Diagnostic Test:
Blood draw
Will receive a one time blood draw to confirm healthy liver status

Locations

Country Name City State
United States Cincinnati Children's Hospital Medical Center Cincinnati Ohio

Sponsors (4)

Lead Sponsor Collaborator
Children's Hospital Medical Center, Cincinnati Children's Hospital of Philadelphia, Massachusetts General Hospital, Washington University School of Medicine

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Liver Stiffness Liver stiffness is a measure of a mechanical property of tissue (stiffness). This can be measured non-invasively by MR elastography, a technique that involves applying an external vibration to the abdomen and measuring the progression of shear waves through the underlying liver using MRI.
Purpose of the study was to determine normal (healthy) liver stiffness as measured by MRE
During investigation
Secondary Cross-platform Variability To assess for cross-platform (different MRI vendors) variability in normal MRI liver stiffness values During Investigation
Secondary Cross-field Strength To assess cross-field strength (1.5T vs. 3T) variability in normal MRI liver stiffness values During investigation
Secondary Sex-related Differences To assess for sex-related (male vs. female) differences in normal MRI liver stiffness values During investigation
See also
  Status Clinical Trial Phase
Recruiting NCT05255042 - Tissue Models for Liver Disease
Completed NCT04473482 - Michigan Alcohol Improvement Network- Alcohol Reduction and Treatment Trial N/A
Not yet recruiting NCT05120557 - Point-of-care Ultrasound Screening and Assessment of Chronic Liver Diseases and NASH N/A
Completed NCT02917408 - Retrospective Study About Primary Biliary Cholangitis During January 2001 to July 2016 at West China Hospital
Recruiting NCT03773887 - Comparison of Inflammatory Profiles and Regenerative Potential in Alcoholic Liver Disease N/A
Recruiting NCT00345930 - DILIN - Prospective Study
Completed NCT00148031 - Improving Hepatitis C Treatment in Injection Drug Users Phase 4
Terminated NCT00031135 - Total Parenteral Nutrition-Associated Liver Disease Phase 2
Completed NCT00005305 - Hepatitis Delta Infections in Hemophiliacs N/A
Completed NCT00005304 - Delta Hepatitis and Liver Disease in Hemophiliacs
Completed NCT00222664 - Qidong Hepatitis B Intervention Study Phase 4
Recruiting NCT06195917 - Robotic-assisted Percutaneous Transhepatic Puncture N/A
Recruiting NCT04551742 - Social & Contextual Impact on Children Undergoing Liver Transplantation
Completed NCT04782050 - Non-invasive Ultrasound Diagnosis of Chronic Liver Diseases in Hepatology Consultation N/A
Completed NCT03614039 - Effect of Probiotic and Smectite Gel on NAFLD N/A
Recruiting NCT04518852 - TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC Phase 2
Recruiting NCT05499585 - Treating Pediatric NAFLD With Nutrition N/A
Terminated NCT03396705 - Liver Regeneration
Completed NCT04341012 - Breath Analysis Based Disease Biomarkers of COVID-19 and Other Diseases
Recruiting NCT05733832 - A Trial of Post-Discharge Transitional Care for Patients With Chronic Liver Disease N/A